Case Report: Metastatic colorectal cancer with ALK–CEP44 fusion and rapid resistance development
BackgroundColorectal cancer rarely harbors rearrangements in the ALK gene, and the therapeutic significance of non-canonical or functionally unclear ALK fusions remains poorly defined. We report a case of metastatic CRC with an ALK–CEP44 fusion not previously described in this tumor type, associated...
Saved in:
| Main Authors: | Silvan Hofmann, Claudine Egger, Silke Potthast, Martin Zoche, Andreas Wicki, Tarun Mehra |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1613235/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dramatic Response to Ensartinib in Metastatic Neuroendocrine Tumors With a Novel CEP44‐ALK Fusion: A Case Report and Literature Review
by: Haiyang Chen, et al.
Published: (2024-12-01) -
Global research trends on ALK-TKIs in non-small cell lung cancer: a bibliometric analysis
by: Yafeng Liu, et al.
Published: (2025-08-01) -
A novel double fusion of EML4-ALK and PLEKHA7-ALK contribute to rapid progression of lung adenocarcinoma: a case report and literature review
by: Zhongzhao Wang, et al.
Published: (2024-11-01) -
Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome
by: Mingyuan Du, et al.
Published: (2024-12-01) -
A new ALK inhibitor overcomes resistance to first‐ and second‐generation inhibitors in NSCLC
by: Yue Lu, et al.
Published: (2021-11-01)